Clinical trialNCT00091507CompletedPhase 3Interventional

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

SponsorTufts Medical CenterEnrollment911Angina, UnstableCardiovascular DiseasesCoronary DiseaseHeart DiseasesHeart Failure, CongestiveMyocardial Infarction

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test the impact of pharmacological myocardial metabolic support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the treatment of patients with threatened or established acute myocardial infarction (AMI).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Harry Selker, MD, MSPH
Tufts Medical Center, Trial Coordinating Center
Study Chair
clinicaltrials.gov ↗
James Udelson, MD
Tufts Medical Center, LV Core Lab
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Ralph D'Agostino, PhD
Tufts Medical Center, Data Coordinating Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Anchorage Site
Anchorage, Alaska, United States
New Haven Site
New Haven, Connecticut, United States
Macon Site
Macon, Georgia, United States
Brockton Site
Brockton, Massachusetts, United States
Concord Site
Concord, Massachusetts, United States
St. Paul Site
Saint Paul, Minnesota, United States
Albuquerque Site
Albuquerque, New Mexico, United States
Hershey Site
Hershey, Pennsylvania, United States
Sioux Falls Site
Sioux Falls, South Dakota, United States
Dallas Site
Dallas, Texas, United States
El Paso Site
El Paso, Texas, United States
Bellingham Site
Bellingham, Washington, United States
Milwaukee Site
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GIKPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2006
Primary completion: 31 Aug 2011
Completion: 31 Aug 2012
Last update posted: 2 Mar 2016
Registered enrollment: 911
Registry id: NCT00091507

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.